PL1747220T3 - Podstawione 1H-pirolo[3,2-b, 3,2-c i 2,3-c]pirydyno-2-karboksyamidy oraz pokrewne analogi jako inhibitory kinazy kazeinowej l epsilon - Google Patents
Podstawione 1H-pirolo[3,2-b, 3,2-c i 2,3-c]pirydyno-2-karboksyamidy oraz pokrewne analogi jako inhibitory kinazy kazeinowej l epsilonInfo
- Publication number
- PL1747220T3 PL1747220T3 PL04812567T PL04812567T PL1747220T3 PL 1747220 T3 PL1747220 T3 PL 1747220T3 PL 04812567 T PL04812567 T PL 04812567T PL 04812567 T PL04812567 T PL 04812567T PL 1747220 T3 PL1747220 T3 PL 1747220T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- compounds
- casein kinase
- carboxamides
- pyrrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52876403P | 2003-12-11 | 2003-12-11 | |
EP04812567A EP1747220B1 (en) | 2003-12-11 | 2004-12-01 | Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
PCT/US2004/040080 WO2005061498A1 (en) | 2003-12-11 | 2004-12-01 | Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1747220T3 true PL1747220T3 (pl) | 2009-09-30 |
Family
ID=34710096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04812567T PL1747220T3 (pl) | 2003-12-11 | 2004-12-01 | Podstawione 1H-pirolo[3,2-b, 3,2-c i 2,3-c]pirydyno-2-karboksyamidy oraz pokrewne analogi jako inhibitory kinazy kazeinowej l epsilon |
Country Status (21)
Country | Link |
---|---|
US (2) | US7402672B2 (pl) |
EP (1) | EP1747220B1 (pl) |
JP (1) | JP4691506B2 (pl) |
KR (1) | KR20060113754A (pl) |
CN (1) | CN100439367C (pl) |
AT (1) | ATE428711T1 (pl) |
AU (1) | AU2004303826A1 (pl) |
BR (1) | BRPI0417520A (pl) |
CA (1) | CA2549183A1 (pl) |
DE (1) | DE602004020685D1 (pl) |
DK (1) | DK1747220T3 (pl) |
ES (1) | ES2324871T3 (pl) |
HK (1) | HK1098742A1 (pl) |
HR (1) | HRP20090380T1 (pl) |
IL (1) | IL175875A0 (pl) |
PL (1) | PL1747220T3 (pl) |
PT (1) | PT1747220E (pl) |
RS (1) | RS50823B (pl) |
SI (1) | SI1747220T1 (pl) |
TW (1) | TW200530234A (pl) |
WO (1) | WO2005061498A1 (pl) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1791537T3 (pl) | 2004-08-19 | 2010-04-30 | Aventis Pharma Inc | Pochodne 3-arylotioindolo-2-karboksamidów i ich analogi jako inhibitory kinazy kazeinowej I |
JO2724B1 (en) * | 2004-08-19 | 2013-09-15 | افينتس فارماسوتيكالز انك | 3-Alternative-5 -6-Amino Alkyl Indole-2-Carboxyl Acid Amide and Related Isotopes as Casein Kinase Inhibitors |
JO2629B1 (en) | 2004-08-19 | 2012-06-24 | افينتيس فارما سوتيكالز انك | Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon |
RU2008112313A (ru) * | 2005-09-01 | 2009-10-10 | Эррэй Биофарма Инк. (Us) | Соединения ингибиторы raf и способы их применения |
CA2626789A1 (en) * | 2005-10-21 | 2007-04-26 | Exelixis, Inc. | Pyrimidinones as casein kinase ii (ck2) modulators |
FR2918061B1 (fr) * | 2007-06-28 | 2010-10-22 | Sanofi Aventis | Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique. |
FR2918986B1 (fr) | 2007-07-19 | 2009-09-04 | Sanofi Aventis Sa | Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique |
FR2939134A1 (fr) | 2008-12-01 | 2010-06-04 | Sanofi Aventis | Derives de 6-cycloamino-3-(1h-pyrrolo°2,3-b!pyridin-4-yl) imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique |
FR2940284B1 (fr) | 2008-12-19 | 2011-02-18 | Sanofi Aventis | Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique |
FR2940285A1 (fr) | 2008-12-19 | 2010-06-25 | Sanofi Aventis | Derives de 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo °1,2-b!-pyridazine et 6-cycloamino-2-furanyl-3- (pyridin-4-yl)imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique |
FR2945289A1 (fr) | 2009-05-11 | 2010-11-12 | Sanofi Aventis | Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique |
EP2493876B1 (en) * | 2009-10-28 | 2014-02-12 | Pfizer Inc | Imidazole derivatives as casein kinase inhibitors |
FR2960876B1 (fr) | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
WO2014111871A1 (en) | 2013-01-17 | 2014-07-24 | Aurigene Discovery Technologies Limited | 4,5-dihydroisoxazole derivatives as nampt inhibitors |
WO2014182033A1 (en) * | 2013-05-08 | 2014-11-13 | Yuhan Corporation | Process for the preparation of pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof |
KR101657599B1 (ko) * | 2013-05-20 | 2016-09-19 | 주식회사유한양행 | 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법 |
TW201605859A (zh) * | 2013-11-14 | 2016-02-16 | 必治妥美雅史谷比公司 | 作為酪蛋白激酶1δ/ε抑制劑之新穎經取代之吡唑并-哌 |
CN104945313A (zh) * | 2015-06-19 | 2015-09-30 | 洪帅金 | 一种2-甲基-3-溴吡啶的制备方法 |
CN104974082A (zh) * | 2015-07-26 | 2015-10-14 | 陈吉美 | 一种2-甲基-4-溴吡啶的制备方法 |
CN105198802A (zh) * | 2015-11-03 | 2015-12-30 | 江苏梦得电镀化学品有限公司 | 一种2-甲基-3-溴吡啶的制备方法 |
US10973820B2 (en) | 2017-12-13 | 2021-04-13 | Facio Intellectual Property B.V. | Compounds for treatment of diseases related to DUX4 expression |
TW202112368A (zh) | 2019-06-13 | 2021-04-01 | 荷蘭商法西歐知識產權股份有限公司 | 用於治療有關dux4表現之疾病的抑制劑組合 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
US5527819A (en) | 1991-09-06 | 1996-06-18 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
BR9405737A (pt) * | 1993-02-24 | 1995-12-05 | Merck & Co Inc | Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC |
EP0763035A4 (en) | 1994-06-09 | 1997-10-01 | Smithkline Beecham Corp | ENDOTHELIN RECEPTOR ANTAGONISTS |
US5977134A (en) | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6432989B1 (en) * | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
BR0213612A (pt) | 2001-10-02 | 2004-08-24 | Upjohn Co | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição |
CA2478715A1 (en) * | 2002-03-13 | 2003-09-25 | Pharmacia & Upjohn Company | Novel pyrazolo [1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
AU2003226724A1 (en) | 2002-03-27 | 2003-10-08 | Glaxo Group Limited | Quinoline and aza-indole derivatives and their use as 5-ht6 ligands |
-
2004
- 2004-12-01 WO PCT/US2004/040080 patent/WO2005061498A1/en active Application Filing
- 2004-12-01 AT AT04812567T patent/ATE428711T1/de not_active IP Right Cessation
- 2004-12-01 PL PL04812567T patent/PL1747220T3/pl unknown
- 2004-12-01 EP EP04812567A patent/EP1747220B1/en active Active
- 2004-12-01 CA CA002549183A patent/CA2549183A1/en not_active Abandoned
- 2004-12-01 BR BRPI0417520-4A patent/BRPI0417520A/pt not_active IP Right Cessation
- 2004-12-01 AU AU2004303826A patent/AU2004303826A1/en not_active Abandoned
- 2004-12-01 US US11/001,533 patent/US7402672B2/en active Active
- 2004-12-01 SI SI200431149T patent/SI1747220T1/sl unknown
- 2004-12-01 KR KR1020067013455A patent/KR20060113754A/ko not_active Application Discontinuation
- 2004-12-01 CN CNB200480040577XA patent/CN100439367C/zh not_active Expired - Fee Related
- 2004-12-01 RS RSP-2009/0302A patent/RS50823B/sr unknown
- 2004-12-01 PT PT04812567T patent/PT1747220E/pt unknown
- 2004-12-01 DE DE602004020685T patent/DE602004020685D1/de active Active
- 2004-12-01 JP JP2006543873A patent/JP4691506B2/ja not_active Expired - Fee Related
- 2004-12-01 DK DK04812567T patent/DK1747220T3/da active
- 2004-12-01 ES ES04812567T patent/ES2324871T3/es active Active
- 2004-12-10 TW TW093138220A patent/TW200530234A/zh unknown
-
2006
- 2006-05-23 IL IL175875A patent/IL175875A0/en unknown
-
2007
- 2007-05-15 HK HK07105112.5A patent/HK1098742A1/xx not_active IP Right Cessation
-
2008
- 2008-04-21 US US12/106,681 patent/US7626027B2/en active Active
-
2009
- 2009-07-03 HR HR20090380T patent/HRP20090380T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
ATE428711T1 (de) | 2009-05-15 |
BRPI0417520A (pt) | 2007-03-06 |
CN1906194A (zh) | 2007-01-31 |
JP2007513950A (ja) | 2007-05-31 |
DK1747220T3 (da) | 2009-08-10 |
EP1747220B1 (en) | 2009-04-15 |
CN100439367C (zh) | 2008-12-03 |
JP4691506B2 (ja) | 2011-06-01 |
US7626027B2 (en) | 2009-12-01 |
EP1747220A1 (en) | 2007-01-31 |
TW200530234A (en) | 2005-09-16 |
US7402672B2 (en) | 2008-07-22 |
AU2004303826A1 (en) | 2005-07-07 |
HRP20090380T1 (hr) | 2009-08-31 |
KR20060113754A (ko) | 2006-11-02 |
HK1098742A1 (en) | 2007-07-27 |
US20050131012A1 (en) | 2005-06-16 |
WO2005061498A1 (en) | 2005-07-07 |
SI1747220T1 (sl) | 2009-08-31 |
ES2324871T3 (es) | 2009-08-18 |
DE602004020685D1 (de) | 2009-05-28 |
IL175875A0 (en) | 2006-10-05 |
CA2549183A1 (en) | 2005-07-07 |
PT1747220E (pt) | 2009-07-08 |
RS50823B (sr) | 2010-08-31 |
US20080200496A1 (en) | 2008-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175875A0 (en) | Substituted 1h-pyrrolo[3,2-b, 3,2-c and 2,3-c] pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon | |
ATE365742T1 (de) | 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren | |
CY1109558T1 (el) | Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων | |
MX337817B (es) | Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas. | |
IL187438A0 (en) | Pyrrolopyridine derivatives and pharmaceutical compositions containing the same | |
EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
BG108207A (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
TW200730525A (en) | Therapeutic agents | |
RS20050041A (en) | Azaindole kinase inhibitors | |
ZA200600579B (en) | Piperazine derivatives and methods of use | |
MY140872A (en) | 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibitory activity, compositions containing such derivatives and the use of such derivatives in the treatment of hypertension and other disorders | |
ATE424402T1 (de) | Imidazopyridinverbindungen | |
TW200621788A (en) | Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase Iε | |
HUP0402270A2 (hu) | [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények | |
GB0112348D0 (en) | Compounds | |
MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
PT828728E (pt) | Di-hidrobenzofuranos de fenilo | |
DE60205455T2 (de) | Naphthyridinderivate | |
CY1110711T1 (el) | Παραγωγα πυραζολο [3,4-d]αζεπινης ως ανταγωνιστες ισταμινης η3 | |
MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
WO2005062992A3 (en) | Substituted melatonin derivatives, process for their preparation, and methods of use | |
TW200621711A (en) | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I ε | |
SE0100297D0 (sv) | New compounds | |
SE0100296D0 (sv) | New compounds | |
SE0100295D0 (sv) | New compounds |